Stellar earnings have these stocks firing🔥

In partnership with

Good day, 360!

Our Hot Stocks have been FIRE lately🔥 -  we have seen some of these alerts rocket 🚀past the MOON 🌝.  To be first in line for the next one, simply text the word “RAGE” to 1-(888) 404-5747 📲. Be the best prepared trader on the Street!

FOCUS LIST🔎

LICY - Up over 44% in the pre-market after reporting better than expected Q3 financial results and closing upsized $475-million loan facility with the U.S. Department of Energy  

UPST - Up over 16% in pre after reporting better than expected financial results, AI growth 

DOCS - Up over 40% in pre after reporting better than expected earnings,  Net income growth of 44%

HOTLIST🔥

LICY - Up over 44% in the pre-market after reporting better than expected Q3 financial results and closing upsized $475-million loan facility with the U.S. Department of Energy

Li-Cycle Holdings Corp. (LICY) engages in the lithium-ion battery resource recovery and lithium-ion battery recycling business in North America.

In the after-hours yesterday, the company reported Q3 2024 financial results.

Highlights include:

• Closed an upsized $475-million loan facility with the U.S. Department of Energy ("DOE") to support development of the Company's Rochester Hub project;

• Completed Rochester Hub internal technical review under the proposed mixed hydroxide precipitate ("MHP") scope and expects annual production of up to approximately 8,250 tonnes of lithium carbonate and up to approximately 72,000 tonnes of MHP;

• Secured 100% off-take agreement with Glencore Ltd. for the MHP production from the Rochester Hub on market terms;

• Achieved strong year-over-year revenue growth of 79% to $8.4 million, which is equal to the previous quarter’s record revenue;

• Lowered selling, general & administrative ("SG&A") expenses by 50% year-over-year to $12.9 million, mainly due to the Company's cash preservation initiatives;

• Prioritizing full financing package to support construction restart at the Rochester Hub and to satisfy requirements for first advance of the DOE loan facility; and

• Working to establish a self-sufficient and financially accretive Spoke business through optimization initiatives and focus on Generation 3 Spokes.

Shares of LICY traded up over 44% in the pre-market in reaction to the positive financial and operational results.

The $4.90 area acted as support in the pre-market and will be an important level to watch.

Above it, targets to the upside are $5.50, $5.77, $6 and then the pre-market high at $6.14. Beyond that, $7, $7.50 and $8.50 come into play.

Below $4.90, targets to the downside are $4.43, $4, $3.50 and then $3.30. 

UPST - Up over 16% in pre after reporting better than expected financial results, AI growth  

Upstart Holdings Inc. (UPST) together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States.

In the after-hours yesterday, the company reported Q3 2024 financial results.

Highlights Include:

• Revenue: Total revenue was $162 million, an increase of 20% from the third quarter of 2023, and up 27% sequentially. Total fee revenue was $168 million, an increase of 14% year-over-year, and up 28% sequentially.

• Transaction Volume and Conversion Rate. 188,149 loans were originated, totaling $1.6 billion across platform in the third quarter of 2024, up 30% from the same quarter of the prior year, and up 43% sequentially. Conversion on rate requests was 16.3% in the third quarter of 2024, up from 9.5% in the same quarter of the prior year.

• Income (Loss) from Operations. Income (loss) from operations was ($45.2) million, down from ($43.8) million in the same quarter of the prior year.

• Net Income (Loss) and EPS. GAAP net income (loss) was ($6.8) million, up from ($40.3) million in the third quarter of the prior year. Adjusted net income (loss) was ($5.3) million, down from ($3.9) million in the same quarter of the prior year. Accordingly, GAAP diluted earnings per share was ($0.07), and diluted adjusted earnings per share was ($0.06) based on the weighted-average common shares outstanding during the quarter.

Shares of UPST traded up over 16% in the pre-market in reaction to the better than expected financial results.

The $66.50 area acted as resistance in the after hours and will be the first major target for bulls to get above.

Above it, targets to the upside are $68, $69 and then the pre-market high at $69.36. Beyond that, $72 and $80 come into play.

Below $66.50, targets to the downside are $63.50, $62, $60.50, $57 and then a gap fill at $55.47.

Join the Conversation

Jason’s stock scanners loaded DAILY 4am EST.

If you have an RB dashboard, login HERE»

CLICK HERE for Jay’s live scanners and chat room.

If you do not have a login »

Create one for FREE here and then login.

DOCS - Up over 40% in pre after reporting better than expected earnings,  Net income growth of 44%

Doximity Inc. (DOCS) operates a cloud-based digital platform for medical professionals in the United States.

In the after-hours yesterday, the company reported its Q2 2025 financial results.

Highlights include:

• Revenue: Revenue of $136.8 million, versus $113.6 million, an increase of 20% year-over-year.

• Net income and non-GAAP net income: Net income of $44.2 million, versus $30.6 million, representing a margin of 32.3%, versus 26.9%. Non-GAAP net income of $61.1 million, versus $45.6 million, representing a margin of 44.7%, versus 40.1%.

• Adjusted EBITDA: Adjusted EBITDA of $76.1 million, versus $54.2 million, an increase of 41% year-over-year, representing adjusted EBITDA margins of 55.7%, versus 47.7%.

• Diluted net income per share and non-GAAP diluted net income per share: Diluted net income per share was $0.22, versus $0.15, while non-GAAP diluted net income per share was $0.30, versus $0.22.

• Operating cash flow and free cash flow: Operating cash flow of $68.3 million, versus $12.9 million, an increase of 430% year-over-year, and free cash flow of $66.8 million, versus $11.6 million, an increase of 475% year-over-year.

"Our clinical workflow tools saw record use in Q2 with over 600,000 unique active prescribers," said Jeff Tangney, co-founder and CEO of Doximity.

Shares of DOCS traded up over 40% in the pre-market in reaction to the better than expected financial results.

The $60 area acted as resistance in the after-hours and now becomes a potential level of support.

Above it, targets to the upside are $62 and then the after-hours high at $64.35. Beyond that, $64.95, $68 and $72 come into play.

Below $60, targets to the downside are $58, $56, $43 and then $47.

WOW! Did you see LottoX yesterday?

TWO 60% winners and one 40% plus winner.* 

LottoX has been crazy hot lately and JW wants you in there.

Use this link for a special $199 per YEAR rate!

MARKET NEWS 📰

Questions or concerns about our products? Email [email protected] © Copyright 2022, RagingBull